A newly recognized set off of mind irritation may provide a recent goal for slowing Alzheimer’s development.
The mind has its personal built-in immune system that identifies threats and responds to them. In Alzheimer’s illness, rising proof reveals that this method turns into persistently overactive. The result’s persistent irritation that damages the connections between mind cells.
In a preclinical examine utilizing human Alzheimer’s mind cells, scientists at Scripps Analysis have recognized a molecular set off behind this course of. The discovering factors to a possible drug goal that would assist management dangerous irritation.
A Molecular Change Behind Irritation
The examine, revealed in Cell Chemical Biology, focuses on a protein referred to as STING. Beneath regular circumstances, STING acts as a part of the immune system’s early warning community. In Alzheimer’s brains, nonetheless, researchers discovered that STING undergoes a chemical change referred to as S-nitrosylation (or SNO, a response involving sulfur, oxygen and nitrogen). This modification drives the protein into an overactive state. When scientists blocked this transformation in a mouse mannequin, mind irritation was decreased.
“It is a new and essential therapeutic goal for Alzheimer’s illness,” says senior writer Stuart Lipton, the Step Household Basis Endowed Chair at Scripps Analysis and a scientific neurologist. “It is thrilling to see that blocking this change in mice reduces irritation and protects the very mind cell connections which are misplaced in Alzheimer’s, particularly as a result of we discovered the identical pathway to be activated in human Alzheimer’s mind samples and in human stem cell-derived fashions.”
Greater than 30 years in the past, Lipton, who additionally co-directs the Neurodegeneration New Medicines Heart at Scripps Analysis, first described S-nitrosylation. On this course of, a molecule associated to nitric oxide (NO) attaches to a cysteine amino acid in proteins, forming “SNO” and altering how the protein behaves.
His lab later confirmed that SNO will be triggered by growing old, irritation, and environmental exposures comparable to air air pollution and wildfire smoke. These modifications can disrupt many proteins all through the physique. This widespread impact, known as a “SNO-STORM,” has been linked to illnesses together with most cancers, Parkinson’s illness, and Alzheimer’s.
Pinpointing STING’s Weak Spot
Within the new examine, researchers took a better take a look at STING, which had already been related to Alzheimer’s-related irritation. Lipton’s group, led by postdoctoral researcher Lauren Carnevale, labored with Professor John Yates III, a mass spectrometry professional at Scripps Analysis and holder of the John Lytton Younger Endowed Chair.
They recognized the precise location the place S-nitrosylation happens on STING, specializing in a single amino acid often called cysteine 148. When this website is modified, STING kinds clusters and units off inflammatory signaling.
Elevated ranges of this altered kind, referred to as SNO-STING, have been detected in postmortem mind tissue from Alzheimer’s sufferers, in lab-grown human mind immune cells uncovered to Alzheimer’s proteins, and in mice with the illness.
Additional experiments revealed that hallmark Alzheimer’s protein clumps, together with amyloid-beta and alpha-synuclein, can instantly set off S-nitrosylation of STING. This implies a suggestions loop. Protein buildup, together with growing old and environmental stress, might spark irritation that produces nitric oxide. That, in flip, modifies STING and amplifies irritation even additional.
Defending Mind Connections
To check this mechanism, the group created a model of STING that lacks cysteine 148, stopping the S-nitrosylation step. When launched right into a mouse mannequin of Alzheimer’s, this modified protein considerably decreased irritation in mind immune cells.
Importantly, it additionally preserved synapses, the connections between nerve cells which are important for reminiscence and pondering. Lack of synapses is carefully linked to cognitive decline in dementia, so defending them is a key purpose in Alzheimer’s analysis.
“What makes this goal significantly promising is that we will quiet the pathological overactivation of STING with out shutting down the conventional immune response,” says Lipton. “You continue to want STING to guard your self from infections, and once we goal cysteine 148, we’re not blocking your entire molecule; we’re simply stopping STING from turning into overactivated.”
Lipton’s group is now creating small molecules designed to dam cysteine 148, with plans to check them in future preclinical research.
Reference: “Redox regulation of neuroinflammatory pathways contributes to break in Alzheimer’s illness mind” by Lauren N. Carnevale, Piu Banerjee, Xu Zhang, Jazmin Navarro, Charlene Okay Raspur, Parth Patel, Tomohiro Nakamura, Emily Schahrer, Henry Scott, Nhi Lang, Jolene Okay. Diedrich, Amanda J. Roberts, John R. Yates and Stuart A. Lipton, 23 April 2026, Cell Chemical Biology.
DOI: 10.1016/j.chembiol.2026.03.017
This work was supported partly by the Nationwide Institutes of Well being (R35 AG071734, U01 AG088679, RF1 AG057409, R01 AG078756, R01 AG056259, R01 DA048882, DP1 DA041722 and R01 AG077046), and the U.S. Division of Protection/U.S. Division of the Military (AR230101).
